ASND ▲ +0.0% - Ascendis Pharma A/S
$ASND - Once-Weekly TransCon® CNP (Navepegritide) to Receive 10 Years of Market Exclusivity Upon Approval in the European Union
06-NOV-2026 08:00 AM ET
Share this post
More filings for $ASND
ASND ▼ -1.8% - Ascendis Pharma A/SNov 5, 2026ASND - Ascendis Pharma A/S - SEC Filing Update (05-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 5, 2026ASND ▲ +0.1% - Ascendis Pharma A/SOct 16, 2026ASND ▲ +1.3% - Ascendis Pharma A/SSep 14, 2026ASND ▲ +1.3% - Ascendis Pharma A/SSep 14, 2026ASND ▼ -3.4% - Ascendis Pharma A/SSep 9, 2026
View full $ASND filing history →💬 Comments
Loading comments…
Leave a comment